To confirm the increased expression of VTN(381–397 a.a.) in OA, we performed nano-LC/Chip MS–MS of serum samples from the healthy controls and the patients with OA or with different chronic inflammatory diseases: RA, AS, SLE, and SSc. Here, VTN is linked to systemic sclerosis.